SQUIZZATO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 20.540
EU - Europa 11.646
AS - Asia 2.615
Continente sconosciuto - Info sul continente non disponibili 31
SA - Sud America 18
OC - Oceania 10
AF - Africa 8
Totale 34.868
Nazione #
US - Stati Uniti d'America 20.518
IT - Italia 5.636
UA - Ucraina 1.934
TR - Turchia 1.373
SE - Svezia 959
RU - Federazione Russa 916
DE - Germania 668
VN - Vietnam 616
IE - Irlanda 567
CN - Cina 526
FI - Finlandia 401
GB - Regno Unito 320
FR - Francia 140
IN - India 51
EU - Europa 31
BE - Belgio 25
CA - Canada 21
NL - Olanda 15
JP - Giappone 14
PT - Portogallo 13
RO - Romania 10
BR - Brasile 8
AU - Australia 7
CL - Cile 6
ES - Italia 6
AT - Austria 5
CH - Svizzera 5
KR - Corea 5
SG - Singapore 5
HU - Ungheria 4
MK - Macedonia 4
IL - Israele 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
EG - Egitto 2
HK - Hong Kong 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
TW - Taiwan 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
MN - Mongolia 1
NP - Nepal 1
PK - Pakistan 1
PR - Porto Rico 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 34.868
Città #
Milan 4.070
Fairfield 3.299
Woodbridge 2.390
Houston 1.743
Ashburn 1.601
Jacksonville 1.530
Chandler 1.396
Seattle 1.326
Ann Arbor 1.253
Wilmington 1.198
Cambridge 1.115
Moscow 886
Izmir 657
Princeton 594
Dublin 566
Dearborn 515
Nyköping 458
Dong Ket 300
Rome 292
Como 168
San Diego 168
San Mateo 154
Ogden 110
Beijing 98
Hefei 69
Kocaeli 67
New York 67
Düsseldorf 58
London 55
Washington 54
Kunming 52
Redmond 47
Nanjing 45
Boardman 35
Norwalk 34
Verona 34
Frankfurt am Main 27
Jinan 27
Nanchang 27
Berlin 22
Redwood City 22
Brussels 20
Guangzhou 19
Falls Church 18
Prescot 18
Kilburn 17
Ponte Lambro 17
Helsinki 15
Shenyang 14
Hounslow 13
Tokyo 13
Zhengzhou 13
Besana In Brianza 12
Chicago 12
Pune 12
Varese 12
Chiswick 11
Toronto 11
Changsha 10
Fuzhou 10
Chongqing 9
Dallas 9
Genoa 8
Hangzhou 8
Philadelphia 8
Ralingen 8
Chengdu 7
Hebei 7
New Bedfont 7
Ningbo 7
Phoenix 7
Quzhou 7
Shaoxing 7
Southwark 7
Wuhan 7
Jinhua 6
São Paulo 6
Trieste 6
West Jordan 6
Xian 6
Acton 5
Bergamo 5
Busto Arsizio 5
Casnate Con Bernate 5
Hanoi 5
Indiana 5
Los Angeles 5
Stockholm 5
Wandsworth 5
Amsterdam 4
Auburn Hills 4
Bollate 4
Budapest 4
Cantu 4
Eppelborn 4
Esslingen am Neckar 4
Islington 4
Istanbul 4
Lappeenranta 4
Monza 4
Totale 27.128
Nome #
10 years of stagnant clinical research in the Italian academic context 975
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 252
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI. 225
Risk of recurrence of unusual site venous thromboembolism 211
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 203
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 195
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review 194
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome 192
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis 191
Heart failure and chronic kidney disease in a registry of internal medicine wards 189
Optimal treatment duration of venous thrombosis 188
Abdominal obesity and the risk of recurrent deep vein thrombosis 187
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature 186
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 186
Patient selection for thromboprophylaxis in medical inpatients 184
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study. 184
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis. 182
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 180
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 180
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 179
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 178
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice 178
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells 178
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable? 176
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis 176
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data 174
Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review 174
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis 172
Prevention of venous thromboembolism and persistent vegetative state: a medical and an ethical issue 171
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature 171
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 171
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study 170
Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data 170
Treating patients with cancer and acute venous thromboembolism 169
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation 169
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism 168
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. 167
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 165
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis 164
A case report and literature review of portal vein thrombosis associated with Cytomegalovirus infection in immunocompetent patients 163
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty 163
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation 162
Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension - A Systematic Review and Meta-Analysis - 162
Thrombosis Associated with Viral Hepatitis 161
Applying EBM in clinical practice 160
Imaging for the diagnosis of pulmonary embolism in very obese patients; a survey among internists and radiologists in Italy and the Netherlands 160
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature 160
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study 160
Statins and secondary prevention of ischemic and hemorrhagic stroke 159
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism 158
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 158
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature 158
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study 157
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy 157
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia 155
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 155
Hypothyroidism and acquired von Willebrand's syndrome: a systematic review 155
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? 154
sRAGE and early signs of cardiac target organ damage in mild hypertensives 152
The role of thrombolytic therapy in pulmonary embolism 150
Statins for acute ischemic stroke 150
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 149
How I treat splanchnic vein thrombosis 149
In vitro effects of Apixaban on 5 different cancer cell lines 149
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. 148
The 8th American college of chest physicians guidelines - A perspective on venous thromboembolism guidelines 148
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment 148
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 148
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis. 147
Oral Anticoagulation Therapy in Heart Failure Patients in Sinus Rhythm: A Systematic Review and Meta-Analysis 147
The effect of thyroid autoantibodies on warfarin stability 147
Antithrombotic therapy and cancer. 146
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 146
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 146
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia 144
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) 144
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: Results of a patient-level meta-analysis 143
Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials 143
Thyroid dysfunction and effects on coagulation and fibrinolysis - a systematic review 142
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 142
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal 141
A systematic review on the effect of aspirin in the prevention of post-operative arterial thrombosis in patients undergoing total hip and total knee arthroplasty 141
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism. 140
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 140
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies 138
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events 138
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. 138
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 135
Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients. 135
Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs 135
The role of the metabolic syndrome in patients with provoked venous thromboembolic events 135
The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis. 134
A new era for venous thromboembolism prevention in medical inpatients 134
Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage: A systematic review 134
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 134
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging. 133
Statins, fibrates, and venous thromboembolism: a meta-analysis. 132
JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease. 132
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events 132
Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: a case report 131
Totale 16.881
Categoria #
all - tutte 110.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.599 0 0 0 0 0 0 0 0 0 386 865 1.348
2019/20207.221 352 297 455 1.402 452 774 1.041 853 578 458 121 438
2020/20216.016 115 570 559 591 397 626 297 498 731 476 480 676
2021/20223.237 383 490 178 106 170 222 146 166 165 532 285 394
2022/20233.874 412 208 309 405 276 830 17 493 571 127 112 114
2023/20247.338 1.062 1.035 1.057 1.228 1.261 599 428 437 172 59 0 0
Totale 35.234